The Influence Of New Revenue Standards On Pharmaceutical Circulation Profession

With the development of the economy,new business models and diversified business types have made the current income standards unable to meet the needs of enterprises.Therefore,new income standards that have converged with international standards have emerged as the times require.Are affected to some extent.The pharmaceutical distribution industry is special in nature and involves people's livelihood.At the same time,it also has a wide range of businesses,including pharmaceuticals,pharmaceutical wholesale and pharmaceutical retail.It is also the most affected company.Most domestic pharmaceutical distribution companies have not yet started to implement the new income standards.The research on the impact of the new income standard on the pharmaceutical distribution industry needs further study.This article aims to reflect the impact of the implementation of the new revenue standards on the pharmaceutical distribution industry through case analysis of the Shanghai Pharmaceutical Group through common case studies.Based on the impact of specific cases,this article proposes areas that companies in the industry should pay attention to or can learn from,And measures that companies can respond to in advance.Mainly from the implementation of the new revenue standards,the impact on the Group's revenue recognition and measurement,financial statements and business management in three aspects,of which the impact on the financial statements is specifically the impact on the statement items,financial indicators and presentation disclosure;The impact of business management is specifically divided into the impact of short-term performance,contract management,and information management.Finally,by analyzing the impact of the new revenue standards on Shanghai Pharmaceuticals Group,the corresponding countermeasures are proposed.The main findings of this study are:(1)After the implementation of the new revenue standards,the pharmaceutical distribution industry can make the timing of revenue recognition more clear and accurate,and the possibility of adopting the net amount method appears in measurement,which can be more accurate according to specific businesses.Reflect the actual income level;(2)under the new income standard,the pharmaceutical circulation industry is more detailed in the recognition of assets and liabilities,but there are problems of insufficient disclosure;(3)the implementation of the new income standard,the internal control of the pharmaceutical circulation industry,Information systems put forward higher applicable requirements.The characteristics and practical significance of this study are the combination of specific cases,which is different from the theoretical research that focuses on the analysis of the differences between the old and new standards.It not only enriches the theoretical research,but also conducts in-depth analysis of the management of the case company from multiple perspectives.Companies in the same industry can provide some reference and help when implementing the new standards.At the same time,the proposed measures can also improve the quality of information disclosure of other companies and enhance horizontal comparability.